United States Ophthalmol Drug Market Report 2017

October 2017 | 99 pages | ID: UCDB5BFE297PEN
QYResearch

Abstracts

In this report, the United States Ophthalmol Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ophthalmol Drug in these regions, from 2012 to 2022 (forecast).

United States Ophthalmol Drug market competition by top manufacturers/players, with Ophthalmol Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Allergan
• Roche
• Valeant
• Regeneron
• Santen
• Bayer
• Pfizer
• Senju
• Akorn

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Retinal disorders drugs
• Allergic, inflammatory and infective drugs
• Glaucoma drugs
• Dry eye drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Ophthalmol Drug for each application, including

• Glaucoma
• Dry eye syndrome
• Retinal diseases
• Other ophthalmic indications

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Ophthalmol Drug Market Report 2017

1 OPHTHALMOL DRUG OVERVIEW

1.1 Product Overview and Scope of Ophthalmol Drug
1.2 Classification of Ophthalmol Drug by Product Category
  1.2.1 United States Ophthalmol Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ophthalmol Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Retinal disorders drugs
  1.2.4 Allergic, inflammatory and infective drugs
  1.2.5 Glaucoma drugs
  1.2.6 Dry eye drugs
1.3 United States Ophthalmol Drug Market by Application/End Users
  1.3.1 United States Ophthalmol Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Glaucoma
  1.3.3 Dry eye syndrome
  1.3.4 Retinal diseases
  1.3.5 Other ophthalmic indications
1.4 United States Ophthalmol Drug Market by Region
  1.4.1 United States Ophthalmol Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ophthalmol Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Ophthalmol Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ophthalmol Drug Status and Prospect (2012-2022)
  1.4.5 New England Ophthalmol Drug Status and Prospect (2012-2022)
  1.4.6 The South Ophthalmol Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Ophthalmol Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ophthalmol Drug (2012-2022)
  1.5.1 United States Ophthalmol Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Ophthalmol Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES OPHTHALMOL DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ophthalmol Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ophthalmol Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ophthalmol Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Ophthalmol Drug Market Competitive Situation and Trends
  2.4.1 United States Ophthalmol Drug Market Concentration Rate
  2.4.2 United States Ophthalmol Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ophthalmol Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPHTHALMOL DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ophthalmol Drug Sales and Market Share by Region (2012-2017)
3.2 United States Ophthalmol Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Ophthalmol Drug Price by Region (2012-2017)

4 UNITED STATES OPHTHALMOL DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ophthalmol Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ophthalmol Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Ophthalmol Drug Price by Type (2012-2017)
4.4 United States Ophthalmol Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OPHTHALMOL DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ophthalmol Drug Sales and Market Share by Application (2012-2017)
5.2 United States Ophthalmol Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPHTHALMOL DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmol Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Ophthalmol Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Ophthalmol Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Valeant
  6.4.2 Ophthalmol Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Valeant Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Regeneron
  6.5.2 Ophthalmol Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Regeneron Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Santen
  6.6.2 Ophthalmol Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Santen Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bayer
  6.7.2 Ophthalmol Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bayer Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.2 Ophthalmol Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Senju
  6.9.2 Ophthalmol Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Senju Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Akorn
  6.10.2 Ophthalmol Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Akorn Ophthalmol Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OPHTHALMOL DRUG MANUFACTURING COST ANALYSIS

7.1 Ophthalmol Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmol Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmol Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmol Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPHTHALMOL DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ophthalmol Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ophthalmol Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Ophthalmol Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Ophthalmol Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ophthalmol Drug
Figure United States Ophthalmol Drug Market Size (K MT) by Type (2012-2022)
Figure United States Ophthalmol Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Retinal disorders drugs Product Picture
Figure Allergic, inflammatory and infective drugs Product Picture
Figure Glaucoma drugs Product Picture
Figure Dry eye drugs Product Picture
Figure United States Ophthalmol Drug Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Ophthalmol Drug by Application in 2016
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Dry eye syndrome Examples
Table Key Downstream Customer in Dry eye syndrome
Figure Retinal diseases Examples
Table Key Downstream Customer in Retinal diseases
Figure Other ophthalmic indications Examples
Table Key Downstream Customer in Other ophthalmic indications
Figure United States Ophthalmol Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmol Drug Sales (K MT) and Growth Rate (2012-2022)
Figure United States Ophthalmol Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmol Drug Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Ophthalmol Drug Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Ophthalmol Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmol Drug Sales Share by Players/Suppliers
Figure 2017 United States Ophthalmol Drug Sales Share by Players/Suppliers
Figure United States Ophthalmol Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ophthalmol Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ophthalmol Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmol Drug Revenue Share by Players/Suppliers
Figure 2017 United States Ophthalmol Drug Revenue Share by Players/Suppliers
Table United States Market Ophthalmol Drug Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Ophthalmol Drug Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Ophthalmol Drug Market Share of Top 3 Players/Suppliers
Figure United States Ophthalmol Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ophthalmol Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ophthalmol Drug Product Category
Table United States Ophthalmol Drug Sales (K MT) by Region (2012-2017)
Table United States Ophthalmol Drug Sales Share by Region (2012-2017)
Figure United States Ophthalmol Drug Sales Share by Region (2012-2017)
Figure United States Ophthalmol Drug Sales Market Share by Region in 2016
Table United States Ophthalmol Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ophthalmol Drug Revenue Share by Region (2012-2017)
Figure United States Ophthalmol Drug Revenue Market Share by Region (2012-2017)
Figure United States Ophthalmol Drug Revenue Market Share by Region in 2016
Table United States Ophthalmol Drug Price (USD/MT) by Region (2012-2017)
Table United States Ophthalmol Drug Sales (K MT) by Type (2012-2017)
Table United States Ophthalmol Drug Sales Share by Type (2012-2017)
Figure United States Ophthalmol Drug Sales Share by Type (2012-2017)
Figure United States Ophthalmol Drug Sales Market Share by Type in 2016
Table United States Ophthalmol Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ophthalmol Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ophthalmol Drug by Type (2012-2017)
Figure Revenue Market Share of Ophthalmol Drug by Type in 2016
Table United States Ophthalmol Drug Price (USD/MT) by Types (2012-2017)
Figure United States Ophthalmol Drug Sales Growth Rate by Type (2012-2017)
Table United States Ophthalmol Drug Sales (K MT) by Application (2012-2017)
Table United States Ophthalmol Drug Sales Market Share by Application (2012-2017)
Figure United States Ophthalmol Drug Sales Market Share by Application (2012-2017)
Figure United States Ophthalmol Drug Sales Market Share by Application in 2016
Table United States Ophthalmol Drug Sales Growth Rate by Application (2012-2017)
Figure United States Ophthalmol Drug Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Novartis Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Novartis Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Allergan Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Allergan Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Roche Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Roche Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Valeant Basic Information List
Table Valeant Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Valeant Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Valeant Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Valeant Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Regeneron Basic Information List
Table Regeneron Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Regeneron Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Regeneron Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Regeneron Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Santen Basic Information List
Table Santen Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Santen Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Santen Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Santen Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Bayer Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Bayer Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Pfizer Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Senju Basic Information List
Table Senju Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Senju Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Senju Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Senju Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Akorn Basic Information List
Table Akorn Ophthalmol Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Akorn Ophthalmol Drug Sales Growth Rate (2012-2017)
Figure Akorn Ophthalmol Drug Sales Market Share in United States (2012-2017)
Figure Akorn Ophthalmol Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmol Drug
Figure Manufacturing Process Analysis of Ophthalmol Drug
Figure Ophthalmol Drug Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmol Drug Major Players/Suppliers in 2016
Table Major Buyers of Ophthalmol Drug
Table Distributors/Traders List
Figure United States Ophthalmol Drug Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmol Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmol Drug Price (USD/MT) Trend Forecast (2017-2022)
Table United States Ophthalmol Drug Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Ophthalmol Drug Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Ophthalmol Drug Sales Volume (K MT) Forecast by Type in 2022
Table United States Ophthalmol Drug Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Ophthalmol Drug Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Ophthalmol Drug Sales Volume (K MT) Forecast by Application in 2022
Table United States Ophthalmol Drug Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Ophthalmol Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmol Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmol Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources